Obstructive Sleep Apnea Syndrome and Complications of Cardiovascular Disorders – the Role of Interdisciplinary Cooperation

Czech version

Authors: E. Sovová ^1,2; M. Hobzová ³; Marek Sova ⁴ ; D. Pastucha ²
Authors‘ workplace: I. interní klinika LF UP a FN Olomouc ¹; Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace LF UP a FN Olomouc ²; Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc ³; LF UP v Olomouci ⁴
Published in: Cesk Slov Neurol N 2010; 73/106(6): 650-655
Category: Review Article

Overview

Obstructive sleep apnea (OSA) is a very common disease involving many risks for patients and it has a substantial influence on mortality and morbidity. Neurologists, pneumologists and cardiologists, as well as internists, all cooperate on the diagnosis and therapy of this disease. The aim of this paper is to summarize recent information about the most severe cardiovascular complications of OSA and to emphasise the importance of interdisciplinary cooperation in the diagnosis and treatment of these patients. The following primary targets for such cooperation include: cost-benefit analysis in the specification of a strategy for patient evaluation; a comprehensive approach to patient treatment with the focus on the influence of all the risk factors for cardiovascular diseases; the realization of randomized trials in which the connection between OSA and cardiovascular diseases is evaluated; and, last but not least, the creation of algorithms of treatment that might improve patient compliance and the outcomes of treatment.

Key words:
obstructive sleep apnea – cardiovascular complication – continual positive airway pressure treatment – multidisciplinary cooperation

Sources

1. Nevšímalová S, Šonka K. Poruchy spánku a bdění. 2nd ed. Praha: Galén 2007: 345.

2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurence of sleep disordered breathing among middle aged adults. N Engl J Med 1993; 328(17): 1230–1235.

3. Bradley TG, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009; 373(9657): 82–93.

4. Šonka K, Slonková J. Spánková apnoe dospělého věku. Cesk Slov Neurol N 2008; 71/104(6): 643–656.

5. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Commitee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institute of Health). J Am Coll Cardiol 2008; 52(8): 686–717.

6. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009; 51(5): 434–451.

7. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 2009; 53(1): 64–69.

8. Peled N, Kassirer M, Kramer MR, Rogowski O, Shlomi D, Fox B et al. Increased erytrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Tromb Res 2008; 121(5): 631–636.

9. Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 2008; 18(7): 253–260.

10. Lopez PP, Stefan B, Schulman CI. Prevalence of sleep apnea in morbidly obese patiens who presented for weight loss surgery evaluation: more evidence for rutine screening for obstructive sleep apnea before weight loss surgery. Am Surg 2008; 74(9): 384–388.

11. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9): 735–741.

12. Punjabi NM, Sahar E, Renine S, Gottlieb DJ, Givelber R, Resnick HE. Sleep disordered breathing, glukose intolerance and insulin resistence. Am J Epidemiol 2004; 160(6): 521–530.

13. Valham F, Stegmayr B, Ericsson M, Hägg E, Lindberg E, Franklin KA. Snoring and witnessed sleep apnea is related to diabetes mellitus in women. Sleep Medicine 2009; 10(1): 112–117.

14. Newman AB, Nieto FJ, Guidry U, Lind BK, Renine S, Shahar E et al. Relation of sleep disordered breathing to cardiovascular disease risc factors. Am J Epidemiol 2001; 154(1): 50–59.

15. Barceló A, Barbé F, de la Peña M, Martinez P, Soriano JB, Piérola J et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63(11): 946–950.

16. Lam J, Ip M. An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med 2007; 13(6): 484–489.

17. Tkacova R, Dorkova Z, Molcanyiova A, Radikova Z, Klimes I, Tkac I. Cardiovascular risk and insulin resistence in patiens with obstructive sleep apnea. Med Sci Monit 2008; 14(9): 438–44.

18. Blažejová K, Šonka K, Škodová Z, Nevšímalová S. Prevalence obezity, hypertenze a kouření u pacientů se syndromem spánkové apnoe- srovnání s českou populací. Čas lék česk 2000; 139(11): 339–342.

19. Szabóová E, Tomci Z, Gonsorčík J, Petrovičová J. Tradičné rizikové faktory aterosklerózy u pacientov so syndrómom obstrukčního spánkového apnoe-hypopnoe. Vnitř Lék 2008; 54(4): 352–360.

20. Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders a a major cause of essential hypertension: fact or fiction? Curr Opin Nephrol Hypertens 1998; 7(4): 353–357.

21. Nieto FJ, Young TB, Lind BK, Sahar E, Samet JM, Renine S et al. Association of sleep-disorderes breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283(14): 1829–1836.

22. Baguet JP, Barone-Rochette G, Pépin JL. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertension 2009; 23(7): 431–443.

23. Logan AG, Perlikowski SM, Mente A, Tishler A, Tkacova R, Niroumand M et al. High prevalence of unrecognised sleep apnoea in drug resistant hypertension. J Hypertens 2001; 19(12): 2271–2277.

24. Moráň M, Kadaňka Z, Blatný M. Kvalita spánku u pacientů se syndromem spánkové apnoe a její ovlivnění léčbou trvalým přetlakem, vztah k hypertenzní chorobě. Cesk Slov Neurol N 2000; 63(4): 209–214.

25. Arias MA, Garcia-Rio F, Alonso- Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross over study. Eur Heart J 2006; 27(9): 1106–1113.

26. Yamakawa H, Shiomi T, Sasanabe R, Hasegawa R, Oottake K, Banno K et al. Pulmonary hypertension in patients with severe obstructive sleep apnea. Psychiatry Clin Neurosci 2002; 56(3): 311–312.

27. Tkáčová R. Spánkové apnoe a ochorenia kardiovaskulárneho systému. Praha: Galén 2006.

28. Sovová E, Hobzová M, Zapletalová J, Kolek V, Lukl J. Funkce pravé komory srdeční a výskyt plicní hypertenze u pacientů se syndromem obstrukční spánkové apnoe. Cesk Slov Neurol N 2008; 71/104(3): 293–297.

29. Sahar E, Whitney CW, Renine S, Lee ET, Newman AB, Nieto FJ et al. Sleep disordered breathing and cardiovascular disease. Cross sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163(1): 19–25.

30. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care 2000; 162(1): 81–86.

31. Sorajja D, Gami AS, Somers VK, Behrenbeck TR, Garcia-Touchard A, Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 2008; 133(4): 927–933.

32. Lee CH, Khoo SM, Tai BC, Chong EY, Lau C, Than Y et al. Obstructive sleep apnea in patiens admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest 2009; 135(6): 1488–1495.

33. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008; 52(5): 343–346.

34. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al. Association of nocturnal arrhythmias with sleep disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173(8): 910–916.

35. Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T et al. Nocturnal arrhythmias across a spektrum of obstructive and sleep disordered breathing in older man. Outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 2009; 169(12): 1147–1155.

36. Grimm W, Hoffmann J, Menz V, Kohler U, Heitmann J, Peter JH et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77(15): 1310–1314.

37. Garrigue S, Pépin JL, Defaye P, Murgatroyd F, Poezevara Y, Clementy J et al. High prevalence of sleep apnea syndrome in patients with long term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115(13): 1703–1709.

38. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T et al. Obstructive sleep apnea, obezity, and the risc of incident atrial fibrilation. J Am Coll Cardiol 2007; 49(5): 565–571.

39. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV et al. Obstructive sleep apnea and the recurrence of atrial fibrilation. Circulation 2003; 107(20): 2589–2594.

40. Jongnarangsin K, Chugh A, Good E, Mukerji S, Dey S, Crawford T et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrilation. J Cardiovasc Electrophysiol 2008; 19(7): 668–672.

41. Pedrosa RP, Drager LF, Genta PR, Amaro ACS, Antunes MO, Matsumoto AY et al. Obstructive sleep apnea is common and indepenently associated with atrial fibrilation in patiens with hypertrophic cardiomyopathy. Chest 2010; 137(5): 1078–1084.

42. Garrigue S, Bordur P, Jais P, Shah DC, Hocini M, Raherisson C et al. Benefit of atrial paging in sleep apnea syndrome. NEJM 2002; 346(6): 404–412.

43. Baranchuk A, Healey JS, Simpson CS, Redfearn DP, Morillo CA, Connolly Sjet al. Atrial overpacing in sleep apnoea: a meta analysis. Europace 2009; 11(8): 1037–1040.

44. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352(12): 1206–1214.

45. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risc factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160(4): 1101–1106.

46. Takasugi N, Nishigaki K, Kubota T, Tsuchiya K, Natsuyama K, Tagasugi M et al. Sleep-apnoea induces cardiac electrical instability assessed by T-wave alternans in patiens with congestive heart failure. Eur J Heart Failure 2009; 11(11): 1063–1070.

47. Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection function. Eur J Heart Failure 2009; 11(6): 602–608.

48. Arzt M, Young T, Finn I, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurence of stroke. Am J Respir Crit Care Med 2005; 172(11): 1447–1451.

49. Vilaplana-Bonnin M, Arboix A, Parra O, Garcia-Eroles L, Montserrat JM, Massons J. Sleep related breathing disorders in acute lacunar stroke. J Neurol 2009; 356(12): 2036–2042.

50. Minoguchi K, Yokoe T, Tazachi T, Minoguchi H, Oda N, Tanaka A et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 175(6): 612–617.

51. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med 2008; 168(3): 297–301.

52. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patiens with coronary artery disease and sleep apnea. A ten year follow up. Circulation 2008; 118 (9): 955–960.

53. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J App Physiol 2008; 105(6): 1852–1857.

54. Dziewas R, Ritter M, Boentert M, Dittrich R, Schäbitz WR, Ringelstein EB et al. Atherosclerosis and obstructive sleep apnea in patiens with ischemic stroke. Cerebrovasc Dis 2007; 24(1): 122–126.

55. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risc. Am J Respir Crit Care Med 2007; 176(12): 1274–1280.

56. Marin JM, Carrizo SJ, Vincente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365(9464): 1046–1053.

57. Doherty LS, Kiely JL, Swan V, McNicolas WT. Long term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea. Chest 2005; 127(6): 2076–2084.

58. Peker Y, Glantz H, Thunström E, Kallryd A, Herlitz J, Ejdebäck J. Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea – RICCADSA trial. Scand Cardiovasc J 2009; 43(1): 24–31.

59. Rodrigues FC, Ronchel JP, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C. Long term effect of continous positive airway pressure on BP in patiens with hypertension and sleep apnea. Chest 2007; 132(6): 1847–1852.

60. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E et al. Impact of continous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnoea: a meta-analysis of randomized controlled trials. Lung 2007; 185(2): 67–72.

61. Arias MA, Garcia-Rio F, Alonso-Fernández A, Martinez I. Pulmonary hypertension in obstructive sleep apnoea: effects od continuous positive airway pressure. Eur Heart J 2006; 27(9): 1106–1113.

62. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenz-Filho G. Effects of continous positive airway pressure on early sign of atherosclerosis in obstructive sleep apnea. Am J Respir Care Med 2007; 176(7): 706–712.

63. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial fiction in obstructive sleep apnea. Prog Cardiovasc Dis 2009; 51(5): 351–362.

64. Shaw JE, Punjabi NM, Wilding JP, Alberti KGMM, Zimmet PZ. Sleep-disorder breathing and type 2 diabetes. A report from the international Diabetes Federation tastforce on epidemiology and prevention. Diabetes Res Clinic Pract 2008; 81(1): 2–12.

65. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patiens with severe obstructive sleep apnea and metabolic syndrome. Chest 2008; 134(4): 686–692.

66. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al. Cardiovascular effects of N Engl J Med 2003; 348(13): 1233–1241.

67. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care 2004; 169(3): 361–366.

68. Arias MA, García-Río F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects og nasal continous positive airway pressure in men. Circulation 2005; 112(3): 375–383.

69. Kasai T, Usui Y, Yoshioka T, Yanagishawa N, Takata Y, Narui K et al. Effect of flow-triggered adaptive servo-ventilation compared with continous positive airway pressure in patiens with chronic heart silure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 2010; 3(1): 140–148.

70. Johnson CB, Beanlands RS, Yoshinaga K, Hamad H, Leech J, de Kemp R et al. Acute and chronic effects of continous positive airway pressure therapy on left ventricular systolic and diastolic function in patiens with obstructive sleep apnea and congestive heart failure. Can J Cardiol 2008; 24(9): 697–704.

71. Haruki N, Takeuchi M, Kanazawa Y, Tsubota N, Shintome R, Nakai H et al. Continous positive airway pressure ameliorates sleep induced subclinical left ventricular systolic dysfunction: demonstration by two dimensional specle-tracnikg echocardiography. Eur J Echocardiography 2010; 11(4): 352–358.

72. Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol 2006; 13(2): 198–200.

73. Martinéz-García MA, Soler- Cataluňa JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB et al. Continous positive airway pressure treatment reduces mortality in patiens with ischemic stroke and obstructive sleep apnea. Am J Respir Crit Care Med 2009; 180(10): 36–41.

74. Javaheri S. Effects of continous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101(4): 392–397.

75. Moráň M, Siegelová J, Kadaňka Z, Fišer B, Cornelissen G, Halberg F et al. Cirkadiánní variabilita krevního tlaku a srdeční frekvence u pacientů se syndromem spánkové apnoe. Cesk Slov Neurol N 2000; 63/96(3): 147–151.